XSHC.L vs. GNOG.L
Compare and contrast key facts about Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L).
XSHC.L and GNOG.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XSHC.L is a passively managed fund by Xtrackers that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Sep 12, 2017. GNOG.L is a passively managed fund by Global X that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Nov 2, 2021. Both XSHC.L and GNOG.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XSHC.L vs. GNOG.L - Performance Comparison
Loading graphics...
XSHC.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | -3.99% | 6.84% | 4.08% | -3.58% | 8.14% | 5.21% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | -1.16% | 12.03% | -16.98% | -11.35% | -29.74% | -10.30% |
Different Trading Currencies
XSHC.L is traded in GBp, while GNOG.L is traded in GBP. To make them comparable, the GNOG.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, XSHC.L achieves a -3.99% return, which is significantly lower than GNOG.L's -1.16% return.
XSHC.L
- 1D
- 0.88%
- 1M
- -5.56%
- YTD
- -3.99%
- 6M
- 5.20%
- 1Y
- 0.60%
- 3Y*
- 3.44%
- 5Y*
- 6.80%
- 10Y*
- —
GNOG.L
- 1D
- 3.29%
- 1M
- -4.36%
- YTD
- -1.16%
- 6M
- 14.72%
- 1Y
- 37.00%
- 3Y*
- -4.91%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XSHC.L vs. GNOG.L - Expense Ratio Comparison
XSHC.L has a 0.12% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.
Return for Risk
XSHC.L vs. GNOG.L — Risk / Return Rank
XSHC.L
GNOG.L
XSHC.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XSHC.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.04 | 1.23 | -1.20 |
Sortino ratioReturn per unit of downside risk | 0.17 | 1.79 | -1.63 |
Omega ratioGain probability vs. loss probability | 1.02 | 1.22 | -0.20 |
Calmar ratioReturn relative to maximum drawdown | 0.14 | 2.22 | -2.08 |
Martin ratioReturn relative to average drawdown | 0.27 | 6.61 | -6.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XSHC.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.04 | 1.23 | -1.20 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.48 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.62 | -0.45 | +1.07 |
Correlation
The correlation between XSHC.L and GNOG.L is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
XSHC.L vs. GNOG.L - Dividend Comparison
XSHC.L's dividend yield for the trailing twelve months is around 1.30%, while GNOG.L has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XSHC.L Xtrackers MSCI USA Health Care UCITS ETF 1D | 1.30% | 1.25% | 1.25% | 1.23% | 1.55% | 0.85% | 1.12% | 0.98% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
XSHC.L vs. GNOG.L - Drawdown Comparison
The maximum XSHC.L drawdown since its inception was -19.16%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for XSHC.L and GNOG.L.
Loading graphics...
Drawdown Indicators
| XSHC.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -19.16% | -67.50% | +48.34% |
Max Drawdown (1Y)Largest decline over 1 year | -12.94% | -17.16% | +4.22% |
Max Drawdown (5Y)Largest decline over 5 years | -19.16% | — | — |
Current DrawdownCurrent decline from peak | -7.25% | -48.74% | +41.49% |
Average DrawdownAverage peak-to-trough decline | -4.71% | -44.07% | +39.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.15% | 5.75% | +0.40% |
Volatility
XSHC.L vs. GNOG.L - Volatility Comparison
The current volatility for Xtrackers MSCI USA Health Care UCITS ETF 1D (XSHC.L) is 4.22%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 9.63%. This indicates that XSHC.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XSHC.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.22% | 9.63% | -5.41% |
Volatility (6M)Calculated over the trailing 6-month period | 9.66% | 21.09% | -11.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.59% | 29.88% | -13.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.07% | 31.32% | -17.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.73% | 31.32% | -15.59% |